Enanta Pharmaceuticals, Inc. (ENTA)

Last Closing Price: 5.93 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Enanta Pharmaceuticals, Inc. (ENTA) had Net Income of $-116.05M for the most recently reported fiscal year, ending 2024-09-30.

Figures for fiscal year ending 2024-09-30
Income Statement Financials
$67.64M
Net Income
$-116.05M
--
$67.64M
$189.33M
$-121.69M
$3.90M
$-117.79M
$-117.79M
$-116.05M
$-116.05M
$-116.05M
$-116.05M
$-121.69M
$-120.49M
21.16M
21.16M
$-5.48
$-5.48
Balance Sheet Financials
$299.85M
$32.69M
$76.80M
$376.65M
$57.53M
--
$190.30M
$247.84M
$128.81M
$128.81M
$128.81M
21.19M
Cash Flow Statement Financials
$-78.76M
$58.23M
$-27.63M
$89.36M
$41.20M
$-48.16M
$26.80M
--
--
Fundamental Metrics & Ratios
5.21
--
--
--
--
100.00%
-179.92%
-179.92%
-178.15%
-174.15%
-171.58%
$-96.71M
--
--
--
0.18
--
1.75
208.55
-90.09%
-90.09%
-30.81%
-90.09%
$6.08
$-4.57
$-3.72